Ubs Asset Management Americas Inc Vera Therapeutics, Inc. Transaction History
Ubs Asset Management Americas Inc
- $477 Billion
- Q2 2025
A detailed history of Ubs Asset Management Americas Inc transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 153,098 shares of VERA stock, worth $4.74 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
153,098
Previous 98,013
56.2%
Holding current value
$4.74 Million
Previous $2.35 Million
53.19%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding VERA
# of Institutions
199Shares Held
64.6MCall Options Held
1.58MPut Options Held
365K-
Avoro Capital Advisors LLC New York, NY6.3MShares$195 Million2.71% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.48MShares$139 Million0.01% of portfolio
-
Kynam Capital Management, LP Princeton, NJ3.43MShares$106 Million9.64% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.35MShares$104 Million1.81% of portfolio
-
Black Rock Inc. New York, NY3.34MShares$103 Million0.0% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $837M
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...